1. Home
  2. ENSC vs MLEC Comparison

ENSC vs MLEC Comparison

Compare ENSC & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.85

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.55

Market Cap

2.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
MLEC
Founded
2003
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENSC
MLEC
Price
$0.85
$7.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.1K
916.2K
Earning Date
03-09-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,487,973.00
N/A
Revenue This Year
N/A
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
1.51
170.36
52 Week Low
$0.76
$3.08
52 Week High
$8.25
$120.00

Technical Indicators

Market Signals
Indicator
ENSC
MLEC
Relative Strength Index (RSI) 33.75 67.65
Support Level $0.76 $4.18
Resistance Level $0.95 $7.79
Average True Range (ATR) 0.10 1.76
MACD 0.02 0.31
Stochastic Oscillator 26.26 40.79

Price Performance

Historical Comparison
ENSC
MLEC

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: